Skip to main content
. 2019 Aug 28;7:e7628. doi: 10.7717/peerj.7628

Table 1. KEGG pathways of DEGs.

Term Genes Type of DEGs P value
Transcriptional misregulation in cancer MEF2C, PROM1, CEBPA, LMO2, FLT3, RUNX1, HMGA2, RUNX2, MEIS1, MYC, WT1 up-regulated 0.000
Acute myeloid leukemia CEBPA, FLT3, RUNX1, MYC up-regulated 0.042
Oxytocin signaling pathway MEF2C, CAMK2D, GUCY1A3, PPP3CA, NFATC3, CACNA2D4 up-regulated 0.056
Proteoglycans in cancer CD44, RRAS2, CAMK2D, HBEGF, PTCH1, MYC, SDC2 up-regulated 0.058
Renin secretion PTGER2, PTGER4, GUCY1A3, PPP3CA up-regulated 0.058
MAPK signaling pathway MEF2C, MAP3K5, RRAS2, GNA12, PPP3CA, NFATC3, MYC, CACNA2D4 up-regulated 0.059
Pathways in cancer CEBPA, PTGER2, PTGER4, FLT3, GNA12, SMAD3, PTCH1, CDK6, RUNX1, MYC up-regulated 0.092
MicroRNAs in cancer SPRY2, CD44, VIM, ZEB2, CDK6, HMGA2, MYC, DDIT4 up-regulated 0.099
Alzheimer’s disease APP, TNF, MME, ITPR3 down-regulated 0.053
TGF-beta signaling pathway TNF, ID3, SMAD1 down-regulated 0.068
Hematopoietic cell lineage TNF, MS4A1, MME down-regulated 0.072

Notes.

KEGG
Kyoto Encyclopedia of Genes and Genomes
DEG
differentially expressed genes